Panfacial botulinum toxin improves patient retention
Braun, M.
Journal of Drugs in Dermatology Jdd 6(2): 131-139
2007
ISSN/ISBN: 1545-9616 PMID: 17373170 Document Number: 13938
The injection of botulinum toxin (Botox, Allergan, Irvine, CA) is the most common cosmetic procedure in the U.S. In the past 5 years, its use has climbed over 388%. In 2005, business development managers from Allergan audited 1695 patient charts from the top 54 cosmetic practices in Canada. Despite the increasing popularity of this nonsurgical treatment, on average only 57% of patients return for a second injection within 6 months. In the author's clinical practice 92% of patients return for a second injection in this time frame. This paper will examine various factors that appear to result in satisfied patients with a high retention rate. This article will show that panfacial botulinum toxin injected in multiple sites with appropriate dosing improves patient retention.
Document emailed within 1 workday
